Identifying the histological and molecular constraints imposed by RB during therapy-induced small cell transformation

Ended Project Grant Awarded Last action

Award ID
W81XWH2210742
Recipient
Awarding agency
Obligated
$547,361

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Philadelphia, PA 19104, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Trustees of the University of Pennsylvania received a $547,361 Project Grant award from the Department of the Army Medical Command to identify the histological and molecular constraints imposed by RB during therapy-induced small cell transformation. The award period runs from August 1, 2022 to July 31, 2024.

The grant supports basic and applied biomedical research under the Military Medical Research and Development program (CFDA 12.420). This program aims to transform military and public health through innovative medical solutions for battlefield injuries and investigations into new care delivery models. Specifically, the University of Pennsylvania grant will fund research into the biological mechanisms that limit the development of small cell lung cancer during cancer treatment, with the goal of improving therapeutic approaches and outcomes for patients.

Quick answers

Who received award W81XWH2210742?

W81XWH2210742 was awarded to The Trustees Of The University Of Pennsylvania by Medical Command (Department of the Army) on August 1, 2022.

How much is award W81XWH2210742 worth?

$547,361 has been obligated on W81XWH2210742.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login